Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5573-5588
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5573
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5573
Figure 8 Model of ischemic preconditioning-induced hypoxia-inducible factor-1α-interleukin-1 receptor antagonist signaling to alleviate hepatic ischemia-reperfusion injury.
Ischemic preconditioning promotes the accumulation of hypoxia-inducible factor (HIF)-1α, which subsequently increases HIF-1α entry into the nucleus and promotes the transcriptional expression of interleukin-1 receptor antagonist (IL-1ra). In turn, this inhibits the pro-inflammatory effects of IL-1β and eventually protects against hepatic ischemia-reperfusion injury. HIF: Hypoxia-inducible factor; IL-1ra: Interleukin-1 receptor antagonist.
- Citation: Wang ZY, Liu Y, Li SP, Li JJ, Zhang Z, Xiao XC, Ou Y, Wang H, Cai JZ, Yang S. Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury. World J Gastroenterol 2022; 28(38): 5573-5588
- URL: https://www.wjgnet.com/1007-9327/full/v28/i38/5573.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i38.5573